A Speedinvest portfolio company

aerska

Sector
Health & Bio
Year Invested
2025
Pioneering RNA medicines to treat, delay, and prevent diseases of the brain.

Dublin-based Aerska, with research operations in London, is leveraging advances in ‘brain shuttles’ to enable targeted delivery of next-generation RNAi therapeutics to the CNS.

By silencing the genes that cause harm, Aerska aims to preserve the minds, protect the memories, and enable our loved ones to live longer, healthier lives.

Ireland
Share
Links
LinkedIn
Related Companies
aerska

Pioneering RNA medicines to treat, delay, and prevent diseases of the brain.

Sector
Health & Bio
Year Invested
2025
BlubBlub

Video modeling and gamified activities to help children improve their speech and language skills.

Sector
Marketplaces & Consumer
Health & Bio
Year Invested
2017
Charles.co

A digital clinic specializing in men’s health.

Sector
Health & Bio
Year Invested
2022
Doccla

Building the next-gen virtual ward company.

Sector
Health & Bio
Growth
Year Invested
2021
Fertifa

Enabling companies, large and small, to put DEI and employee well-being into practice.

Sector
Health & Bio
Year Invested
2022
Five Lives

Building digital tools for the tracking and improvement of cognitive health.

Sector
Health & Bio
Year Invested
2022
Flinn

Enabling MedTech companies to automate quality & regulatory processes to launch and operate products 10x more efficiently.

Sector
Health & Bio
Year Invested
2022
Fuse

Bringing price transparency to US healthcare.

Sector
Health & Bio
Year Invested
2025